Dr. Afzal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
# Hospital
Lebanon, NH 03756Phone+1 603-650-8380
Education & Training
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 2020 - 2023
- Ohio state UniversityMS, Clinical Pharmacology, Clinical Research , 2016 - 2017
- Carle Foundation HospitalChief Residency, Internal Medicine, 2014 - 2015
- Corewell Health – Grand Rapids/Michigan State UniversityResidency, Internal Medicine, 2011 - 2014
- King Edward Medical UniversityClass of 2008
- Government College LahoreFSc, 2002
Certifications & Licensure
- VT State Medical License 2023 - 2026
- NH State Medical License 2015 - 2025
- NY State Medical License 2022 - 2024
- MD State Medical License 2015 - 2022
- WV State Medical License 2019 - 2022
- IL State Medical License 2014 - 2017
- MI State Medical License 2011 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Potential Therapeutic Targets for the Treatment of HPV-Associated Malignancies.Ziyao Lu, Shahab Haghollahi, Muhammad Afzal
Cancers. 2024-10-14 - 1 citationsEvolving Management of Breast Cancer in the Era of Predictive Biomarkers and Precision Medicine.Muhammad Zubair Afzal, Linda T Vahdat
Journal of Personalized Medicine. 2024-07-03 - Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors.Yuanzhen Cao, Muhammad Zubair Afzal, Edward J Gutmann, Keisuke Shirai
Melanoma Research. 2024-02-01
Journal Articles
- Metastatic Uveal Melanoma Showing Complete Remission to Anti-CTLA4 and Anti-PD-1 Combination Therapy after Experiencing Progression on Anti-CTLA4 aloneAfzal MZ, Mabaera R, Keisuke S, Journal for ImmunoTherapy of Cancer, 1/1/2018
- Immune Checkpoint Inhibitor (Anti-CTLA-4, Anti-PD-1) Therapy Alone versus Immune Checkpoint Inhibitor (Anti-CTLA-4, Anti-PD-1) Therapy in Combination with Anti-RANKL D...Afzal MZ, Keisuke S, Melanoma Research, 1/1/2018
- An Ingestion of Industrial Strength Hydrogen Peroxide Resulting in Cerebral Embolism and DeathAfzal MS, Dar SS, Sarwar T, Afzal MZ, American Journal of Medical Case Reports, 1/1/2017
- Join now to see all
Abstracts/Posters
- "Recognizing these signs "Will Save Lives"...Classical features of catastrophic syndrome.Hashmi H, Afzal MZ, National ACP Meeting, Boston, MA, 1/1/2015
- Positron emission tomography- computed tomography (PET- CT) in assessment of neuroendocrine prostate cancer (NEPC).Martin R, Fareedy SB, Chalasani SR, Tarlington SL, Belal SL, Afzal MZ, Spratt D, Osborn J, 2014 New England Symposium, 1/1/2014
- Utility of Lower Extremity Doppler in Patients with Lower Extremity Cellulitis: A Need to Change the Practice?Afzal MZ, Mian M, Razvi S, Hashmi H, Lampen R, ACP Associate Day, 1/1/2014
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: